Literature DB >> 11226436

Catalytic activities of membrane-type 6 matrix metalloproteinase (MMP25).

W R English1, G Velasco, J O Stracke, V Knäuper, G Murphy.   

Abstract

This study describes the biochemical characterisation of the catalytic domain of membrane-type 6 matrix metalloproteinase (MT6-MMP, MMP25, leukolysin). Its activity towards synthetic peptide substrates, components of the extracellular matrix and inhibitors of MMPs was studied and compared with MT1-MMP, MT4-MMP and stromelysin-1. We have found that MT6-MMP is closer in function to stromelysin-1 than MT1 and MT4-MMP in terms of substrate and inhibitor specificity, being able to cleave type-IV collagen, gelatin, fibronectin and fibrin. However, it differs from stromelysin-1 and MT1-MMP in its inability to cleave laminin-I, and unlike stromelysin-1 cannot activate progelatinase B. Our findings suggest that MT6-MMP could play a role in cellular migration and invasion of the extracellular matrix and basement membranes and its activity may be tightly regulated by all members of the TIMP family.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11226436     DOI: 10.1016/s0014-5793(01)02150-0

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  25 in total

1.  Using fluorogenic peptide substrates to assay matrix metalloproteinases.

Authors:  G B Fields
Journal:  Methods Mol Biol       Date:  2001

Review 2.  MMPs and TIMPs--an historical perspective.

Authors:  J Frederick Woessner
Journal:  Mol Biotechnol       Date:  2002-09       Impact factor: 2.695

3.  MT6-MMP is present in lipid rafts and faces inward in living human PMNs but translocates to the cell surface during neutrophil apoptosis.

Authors:  Carl F Fortin; Anjum Sohail; Qing Sun; Patrick P McDonald; Rafael Fridman; Tamàs Fülöp
Journal:  Int Immunol       Date:  2010-05-25       Impact factor: 4.823

4.  Characterization of the dimerization interface of membrane type 4 (MT4)-matrix metalloproteinase.

Authors:  Anjum Sohail; Marta Marco; Huiren Zhao; Qicun Shi; Scott Merriman; Shahriar Mobashery; Rafael Fridman
Journal:  J Biol Chem       Date:  2011-08-02       Impact factor: 5.157

5.  Matrix metalloproteinases as reagents for cell isolation.

Authors:  Anna M Knapinska; Sabrina Amar; Zhong He; Sandro Matosevic; Claudia Zylberberg; Gregg B Fields
Journal:  Enzyme Microb Technol       Date:  2016-07-20       Impact factor: 3.493

6.  The compendium of matrix metalloproteinase expression in the left ventricle of mice following myocardial infarction.

Authors:  Amanda R Kaminski; Edwin T Moore; Michael J Daseke; Fritz M Valerio; Elizabeth R Flynn; Merry L Lindsey
Journal:  Am J Physiol Heart Circ Physiol       Date:  2020-02-21       Impact factor: 4.733

7.  Ovarian membrane-type matrix metalloproteinases: induction of MMP14 and MMP16 during the periovulatory period in the rat, macaque, and human.

Authors:  Muraly Puttabyatappa; Terry A Jacot; Linah F Al-Alem; Katherine L Rosewell; Diane M Duffy; Mats Brännström; Thomas E Curry
Journal:  Biol Reprod       Date:  2014-06-11       Impact factor: 4.285

Review 8.  MT4-(MMP17) and MT6-MMP (MMP25), A unique set of membrane-anchored matrix metalloproteinases: properties and expression in cancer.

Authors:  Anjum Sohail; Qing Sun; Huiren Zhao; M Margarida Bernardo; Jin-Ah Cho; Rafael Fridman
Journal:  Cancer Metastasis Rev       Date:  2008-06       Impact factor: 9.264

9.  Matrix metalloproteinase-25 has a functional role in mouse secondary palate development and is a downstream target of TGF-β3.

Authors:  Graham D Brown; Adil J Nazarali
Journal:  BMC Dev Biol       Date:  2010-09-01       Impact factor: 1.978

10.  New Strategies for the Next Generation of Matrix-Metalloproteinase Inhibitors: Selectively Targeting Membrane-Anchored MMPs with Therapeutic Antibodies.

Authors:  Laetitia Devy; Daniel T Dransfield
Journal:  Biochem Res Int       Date:  2010-10-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.